BeStock  
Stocks › Biotechnology › CTMX

CytomX CTMX

US equityMarket cap rank #3673Biotechnology
$2.55 −$0.01 (-0.39%)
Pre-market · Oct 8, 8:10 am ET · After hours $2.54 -0.39%
Open$2.53
Prev close$2.56
Day range$2.52 – $2.65
Volume2.34M
Market cap$555.64M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$13.25+419.6% vs. price
  • Buy 100%
Low $11.00Now $2.55Avg $13.25High $16.00

Recent rating changes

The last 20 actions on file set price targets from $6.00 to $17.00, averaging $12.85.

DateFirmRatingTarget
23 Sep 2026 Piper Sandler BUY $12.00
17 Aug 2026 J.P. Morgan BUY $11.00
13 Aug 2026 J.P. Morgan BUY $11.00
7 Aug 2026 Piper Sandler BUY $12.00
7 Aug 2026 Guggenheim BUY $14.00
7 Aug 2026 Barclays BUY $16.00
4 Jun 2026 Wedbush BUY $11.00
19 May 2026 Wolfe Research BUY $6.00
11 May 2026 H.C. Wainwright BUY $11.00
8 May 2026 Piper Sandler BUY $12.00
8 May 2026 Wedbush BUY $11.00
8 May 2026 Barclays BUY $16.00
7 May 2026 Guggenheim BUY $15.00
23 Mar 2026 Piper Sandler BUY $12.00
20 Mar 2026 Cantor Fitzgerald BUY $12.00
19 Mar 2026 Barclays BUY $16.00
18 Mar 2026 Jefferies BUY $16.00
17 Mar 2026 Wedbush BUY $11.00
17 Mar 2026 Guggenheim BUY $15.00
16 Mar 2026 H.C. Wainwright BUY $17.00

Discussion

No comments yet — be the first to weigh in on CTMX.

Leave a comment

Scroll to Top